Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
SONX Sonendo
2.560-0.040-1.54%
Close
02/03 16:00 ET
High
2.590
Open
2.570
Turnover
177.46K
Low
2.400
Pre Close
2.600
Volume
70.17K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
BIOLASE REJECTS SONENDO'S "PATENTLY ABSURD" CLAIMS
Biolase Said It Rejects Sonendo's "Patently Absurd" Claims
BIOLASE, Inc. (NASDAQ:BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by Sonendo, Inc., through its wholly-owned subsidiary PIPStek L
Sonendo Unveils New Branding and Website; Champions Clinicians Performing Root Canal Treatment
The Campaign Is a Testament to the Dental Technology Company's Continued Investment in Doctors and Their Patients LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental te
Sonendo (NYSE:SONX) Price Target Cut to $5.75 by Analysts at Morgan Stanley
Sonendo (NYSE:SONX – Get Rating) had its price objective reduced by Morgan Stanley from $6.35 to $5.75 in a research report sent to investors on Friday morning, Benzinga reports. Morgan Stanley curre
Morgan Stanley Sticks to Their Hold Rating for Sonendo (SONX)
Morgan Stanley Ajdusts Sonendo's Price Target to $5.75 From $6.35, Keeps Equalweight Rating
11:26 AM EST, 01/06/2023 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
Sonendo Price Target Cut to $5.75/Share From $6.35 by Morgan Stanley
Sonendo Price Target Cut to $5.75/Share From $6.35 by Morgan Stanley
Sonendo Is Maintained at Equal-Weight by Morgan Stanley
Sonendo Is Maintained at Equal-Weight by Morgan Stanley
Sonendo Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/06/2023 199.48% Morgan Stanley $6.35 → $5.75 Maintains Equal-Weight 11/10/2022 230.73% Morgan Stanley $
Morgan Stanley Maintains Equal-Weight on Sonendo, Lowers Price Target to $5.75
Morgan Stanley analyst Erin Wright maintains Sonendo (NYSE:SONX) with a Equal-Weight and lowers the price target from $6.35 to $5.75.
Company Overview
More
Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. It offers practice management software to enable an integrated digital office for dental practitioners. The company was founded by Olav B. Bergheim in 2006 and is headquartered in Laguna Hills, CA.
CEO： Mr. Bjarne Bergheim
Market： NYSE
Listing Date： 10/29/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet